Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins (original) (raw)

References

• Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D and Theillet C . (1991). Oncogene, 6, 659–663.
• Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG . (1995). J. Biol. Chem., 270, 23589–23597.
• Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M and Bartek J . (1994). Int. J. Cancer, 57, 353–361.
• Basilico C and Moscatelli D . (1992). Adv. Cancer Res., 59, 115–165.
• Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V and Le B . (2000). Cytokine Growth Factor Rev., 11, 295–302.
• Chodosh LA, Gardner HP, Rajan JV, Stairs DB, Marquis ST and Leder PA . (2000). Dev. Biol., 219, 259–276.
• Connell-Crowley L, Harper JW and Goodrich DW . (1997). Mol. Biol. Cell, 8, 287–301.
• Cross MJ and Claesson-Welsh L . (2001). Trends Pharmacol. Sci., 22, 201–207.
• Cross MJ, Hodgkin MN, Roberts S, Landgren E, Wakelam MJ and Claesson-Welsh L . (2000). J. Cell Sci., 113 (Part 4), 643–651.
• Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S and Theillet C . (2000). Cancer Res., 60, 1077–1083.
• Daksis JI, Lu RY, Facchini LM, Marhin WW and Penn LJ . (1994). Oncogene, 9, 3635–3645.
• Dickson C, Fantl V, Gillett C, Brookes S, Bartek J, Smith R, Fisher C, Barnes D and Peters G . (1995). Cancer Lett., 90, 43–50.
• Diehl JA, Cheng M, Roussel MF and Sherr CJ . (1998). Genes Dev., 12, 3499–3511.
• Ethier SP, Mahacek ML, Gullick WJ, Frank TS and Weber BL . (1993). Cancer Res., 53, 627–635.
• Gerwins P, Skoldenberg E and Claesson-Welsh L . (2000). Crit. Rev. Oncol. Hematol., 34, 185–194.
• Giri D, Ropiquet F and Ittmann M . (1999). Clin. Cancer Res., 5, 1063–1071.
• Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin Jr AS . (1999). Mol. Cell. Biol., 19, 5785–5799.
• Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas III CF and Hynes NE . (2003). Proc. Natl. Acad. Sci. USA, 100, 8933–8938.
• Hosokawa Y and Arnold A . (1998). Genes Chromosomes Cancer, 22, 66–71.
• Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S, Lehtovirta P and Nevanlinna H . (1993). Int. J. Cancer, 54, 378–382.
• Jang JH, Shin KH and Park JG . (2001). Cancer Res., 61, 3541–3543.
• Kim I, Moon S, Yu K, Kim U and Koh GY . (2001). Biochim. Biophys. Acta, 1518, 152–156.
• Klint P and Claesson-Welsh L . (1999). Front. Biosci., 4, D165–D177.
• Kornmann M, Ishiwata T, Beger HG and Korc M . (1997). Oncogene, 15, 1417–1424.
• Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J . (1997). Cell, 89, 693–702.
• Koziczak M, Krek W and Nagamine Y . (2000). Mol. Cell. Biol., 20, 2014–2022.
• Lane HA, Beuvink I, Motoyama AB, Daly JM, Neve RM and Hynes NE . (2000). Mol. Cell. Biol., 20, 3210–3223.
• Lavia P and Jansen-Durr P . (1999). BioEssays, 21, 221–230.
• Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P and Rosen N . (1994). Oncogene, 9, 1925–1929.
• Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG and Kanakura Y . (1999). EMBO J., 18, 1367–1377.
• Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J and Hubbard SR . (1998). EMBO J., 17, 5896–5904.
• Morgan DO . (1995). Nature, 374, 131–134.
• Nagata D, Suzuki E, Nishimatsu H, Satonaka H, Goto A, Omata M and Hirata Y . (2001). J. Biol. Chem., 276, 662–669.
• Neve RM, Holbro T and Hynes NE . (2002). Oncogene, 21, 4567–4576.
• Neve RM, Sutterluty H, Pullen N, Lane HA, Daly JM, Krek W and Hynes NE . (2000). Oncogene, 19, 1647–1656.
• Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J and Lax I . (2000). Mol. Cell. Biol., 20, 979–989.
• Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J and Lax I . (2001). Proc. Natl. Acad. Sci. USA, 98, 6074–6079.
• Ornitz DM and Itoh N . (2001). Genome Biol., 2, REVIEWS3005.
• Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D and deLapeyriere O . (1995). Int. J. Cancer, 61, 170–176.
• Plotnikov AN, Hubbard SR, Schlessinger J and Mohammadi M . (2000). Cell, 101, 413–424.
• Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JP, Santa LB, Duret L and Vuillaume M . (1994). Blood, 83, 3689–3696.
• Sherr CJ . (1996). Science, 274, 1672–1677.
• Sherr CJ and Roberts JM . (1999). Genes Dev., 13, 1501–1512.
• Suyama K, Shapiro I, Guttman M and Hazan RB . (2002). Cancer Cell, 2, 301–314.
• Tetsu O and McCormick F . (1999). Nature, 398, 422–426.
• Theillet C, Adelaide J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P and Gaudray P . (1993). Genes Chromosomes Cancer, 7, 219–226.
• Valve E, Martikainen P, Seppanen J, Oksjoki S, Hinkka S, Anttila L, Grenman S, Klemi P and Harkonen P . (2000). Int. J. Cancer, 88, 718–725.
• Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV . (1994). Nature, 369, 669–671.
• Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH and Williams LT . (1994). Science, 266, 819–822.
• Yamaguchi F, Saya H, Bruner JM and Morrison RS . (1994). Proc. Natl. Acad. Sci. USA, 91, 484–488.
• Yayon A, Ma YS, Safran M, Klagsbrun M and Halaban R . (1997). Oncogene, 14, 2999–3009.

Download references